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Summary
Leptin has pleiotropic effects on glucose homeostasis and feeding behavior. Here, we validate the use of a cell-permeable
phosphopeptide that blocks STAT3 activation in vivo. The combination of this biochemical approach with stereotaxic
surgical techniques allowed us to pinpoint the contribution of hypothalamic STAT3 to the acute effects of leptin on food
intake and glucose homeostasis. Leptin’s ability to acutely reduce food intake critically depends on intact STAT3 signaling.
Likewise, hypothalamic signaling of leptin through STAT3 is required for the acute effects of leptin on liver glucose fluxes.
Lifelong obliteration of STAT3 signaling via the leptin receptor in mice (s/s mice) results in severe hepatic insulin resistance
that is comparable to that observed in db/db mice, devoid of leptin receptor signaling. Our results demonstrate that the
activation of the hypothalamic STAT3 pathway is an absolute requirement for the effects of leptin on food intake and hepatic
glucose metabolism.Introduction
The increased incidence of type 2 diabetes mellitus and of other
components of themetabolic syndromeclosely follows the rapid
growth in theworldwideprevalence of obesity (Kopelman, 2000).
This epidemiological association fuels the quest for a better
understanding of the mechanisms by which defects in energy
homeostasis are coupled to alterations in glucose and lipid ho-
meostasis (Flier, 2004). The adipocyte-derived hormone leptin
has pleiotropic effects that include major roles in the regulation
of energy metabolism (Pelleymounter et al., 1995; Halaas et al.,
1995) as well as glucose homeostasis (Liu et al., 1998; Coppari
et al., 2005; Schwartz et al., 1996; Chinookoswong et al., 1999;
Morton et al., 2005; Barzilai et al., 1997), lipidmetabolism (Unger
et al., 1999; Frederich et al., 1995; Mantzoros et al., 1998), and
reproductive function (Chehab et al., 1996). Mice deficient in
either leptin (ob/ob) or the leptin receptor (db/db) display hyper-
phagia and decreased metabolic rate, marked alterations in
insulin action and lipid and carbohydrate metabolism, and infer-
tility with hypothalamic hypogonadism (Ahima and Flier, 2000).
Leptin hasbeen shown to acutely restore the luteinizing hormone
(LH) surge in estradiol- and progesterone-primed rats that are
starved (Watanobe et al., 1999). This is thought to be a mecha-
nismbywhich the administration of recombinant leptin improves
ovulatory function in patients with hypothalamic amenorrhea
(Welt et al., 2004). Given that brain-selective knockouts of the
long form of the leptin receptor (LRb) faithfully replicate the met-
abolic aswell as reproductive effects of awhole-body deficiency
of leptin receptors (Cohen et al., 2001), these pleiotropic actions
of leptin appear to be due to its interaction with receptors in the
central nervous system (CNS).
LRb belongs to the class I family of cytokine receptors (Tarta-
glia et al., 1995). Binding of leptin to LRb results in the activationCELL METABOLISM 4, 49–60, JULY 2006 ª2006 ELSEVIER INC. DOof Janus tyrosine kinase 2 (Jak2) and leads to the phosphoryla-
tion of cytoplasmic target proteins, including signal transducer
and activator of transcription (STAT) 3 and the ras/mitogen-
activated protein kinase (MAPK) (Ghilardi et al., 1996; Vaisse
et al., 1996; Baumann et al., 1996).
Genetic models have provided insight into the role of neuronal
STAT3 in energy balance, reproduction, and intermediate
metabolism. Mice with a neuron-specific disruption of STAT3
throughout the CNS are hyperphagic, obese, diabetic, and infer-
tile (Gao et al., 2004). Furthermore, the deletion of STAT3 via the
rat insulin promoter (RIP) leads to a tissue-specific knockout of
STAT3 in a subset of hypothalamic cells (in addition to pancre-
atic b cells), leading to impaired glucose tolerance and obesity
(Cui et al., 2004; Gorogawa et al., 2004; Lee and Hennighausen,
2005). Thus, lifelong deletion of brain or hypothalamic STAT3
leads to obesity and impaired glucose tolerance. Similarly, ho-
mologous replacement of the leptin receptor in mice by a recep-
tor mutant containing a Y1178S mutation (which abrogates
STAT3 signaling) results in animals (s/s) that largely recapitulate
the hyperphagia and obesity of db/db mice (Bates et al., 2003).
Importantly, s/s mice exhibit improved glycemic control com-
pared to db/db mice and display relatively normal reproductive
function (Bates et al., 2005). Because leptin signaling via STAT3
is chronically obliterated, while signaling through STAT3-inde-
pendent signaling pathways is intact in this model, the lower
plasma glucose levels and the preserved, albeit decreased re-
productive capacity in these animals presumably reflects the
function of STAT3-independent pathways by leptin (Bates and
Myers, 2003).
Leptin activation of other signaling molecules downstream of
LRb, such as the phosphoinositide-3-kinase (PI3K) (Niswender
et al., 2001; Morton et al., 2005) and central melanocortin recep-
tors (Seeley et al., 1997), has been shown to be required for itsI 10.1016/j.cmet.2006.04.014 49
A R T I C L EFigure 1. A cell-permeable SH2 domain binding phosphopeptide inhibits leptin-induced STAT3 Y705 phosphorylation in the arcuate nucleus
A) Mechanism by which the STAT3 PI inhibits STAT3 activation: upon phosphorylation of Y705, STAT3 forms homodimers and translocates into the nucleus. The phos-
phopeptides bind to the SH2 domain of STAT3 and inhibit the recruitment of STAT3 to Jak2 and the phosphorylation of Y705. This in turn leads to inhibition of STAT3 di-
merization, nuclear translocation, and transcriptional activity. Nuclear STAT3 rapidly promotes the transcription of SOCS3.
B and C) In vivo validation of the STAT3 PI. Rats received first either vehicle or the Stat3 PI (75 pmol) as indicated. Thirty minutes later, rats received either 2.5 mg of re-
combinant leptin 6 the STAT3 PI or the control peptide (75 pmol). Thirty minutes after leptin administration, rats were sacrificed and the arcuate nucleus of the hypothal-
amus was isolated by punch biopsy, homogenized, and analyzed byWestern blot (B) and quantified by imagequant software. Leptin-induced STAT3 phosphorylation was50 CELL METABOLISM : JULY 2006
Leptin regulation of liver glucose metabolismacute effects on feeding behavior. On the other hand, despite
the critical role that STAT3 plays in cytokine signal transduction
and in the chronicmodulation of energy homeostasis, the lack of
specific inhibitors of STAT3 activation has so far hampered the
investigation of its role in mediating the acute effects of leptin.
The importance of understanding the role of signaling pathways
under acute conditions is highlighted not only by the confound-
ing hormonal and metabolic complications that accompany
chronic leptin deficiency, but by emerging evidence for the im-
portant role of leptin and of other central pathways during pre-
and early postnatal development of neural circuits (Bouret
et al., 2004). These latter considerations are particularly relevant
for STAT3 due to its established role in cell growth and differen-
tiation (Hirabayashi and Gotoh, 2005). Thus, the identification
of the role of STAT3 in mediating leptin’s pleiotropic actions
requires molecular and biochemical strategies designed to
acutely andselectively obliterate leptin signaling inadult animals.
Here, using the stereotaxic delivery of a cell-permeable phos-
phopeptide inhibitor of STAT3 phosphorylation/dimerization or
of an adenovirus expressing a dominant-negative (DN) STAT3
mutant, we assess the contribution of the STAT3 signaling path-
way to the acute effects of leptin on food intake, glucose metab-
olism, and gonadotropin secretion. Additionally, we directly
measured the effects of insulin on glucose metabolism in con-
scious s/s and db/db mice by means of the insulin clamp tech-
nique. Our results identify STAT3 as essential for mediating the
acute effects of leptin not only on food intake but also on gonad-
otropin secretion and on hepatic glucose fluxes.
Results
In vivo validation of the cell-permeable STAT3 PI
Upon leptin receptor activation, cytoplasmic STAT3 gets re-
cruited to Tyr1138 of LRb, mediating the Jak2-dependent phos-
phorylation of STAT3 on Y705. This allows for the formation and
nuclear translocation of STAT3 homodimers, which function as
transcription factors (Figure 1A). The STAT3 peptide inhibitor
(STAT3 PI) is a Src homology 2 (SH2) domain binding phospho-
peptide that prevents recruitment of STAT3 to Jak2 and phos-
phorylation of Y705, thereby impeding the dimerization and
the nuclear translocation of STAT3 (Turkson et al., 2001) (Fig-
ure 1A). Here, we demonstrate that the central administration
of this STAT3 PI selectively negates leptin’s ability to phosphor-
ylate/activate STAT3 in the mediobasal hypothalamus (MBH). A
single intracerebroventricular (ICV) bolus injection of 2.5 mg of
recombinant leptin in conscious rats induced the activation of
STAT3 in arcuate nucleus extracts derived bymicro punch biop-
sies (Figures 1B–1D). Infusion of the STAT3 PI (75 pmol) into the
third cerebral ventricle did not alter STAT3 and MAPK under
basal conditions but prevented the leptin-induced STAT3 acti-
vation at 30 min (Figure 1B) and 180 min (Figure 1C) after leptin
ICV injection. The preinfusion followed by coinfusion of a scram-
bled sequence (control) peptide with leptin failed to alter leptin
stimulation of STAT3 phosphorylation (Figure 1B). Thus, theCELL METABOLISM : JULY 2006central administration of this STAT3 PI can completely obliterate
the effects of ICV leptin on STAT3, and this inhibition is sus-
tained for at least 3 hr (Figure 1C). Importantly, the effect of leptin
on the MAPK pathway did not require STAT3 activation, since
the phosphorylation of extracellular signal-regulated kinases
(ERKs) ERK1 and ERK2 was equally enhanced by ICV leptin
in the presence of vehicle, STAT3 PI, and control peptide (Fig-
ure 1B). Leptin induces the dimerization and nuclear transloca-
tion of STAT3. Nuclear STAT3, in turn, modulates the transcrip-
tion of various genes (Figure 1A). The rapid induction of the
suppressor of cytokine signaling-3 (SOCS3) transcription by
leptin (Bjorbaek et al., 1998) is dependent on STAT3 activation
and has been used as an index of leptin’s transcriptional activity
in neurons (Bjorbaek et al., 1998;Munzberg et al., 2003). In order
to probe the effect of the STAT3 PI on leptin-induced transcrip-
tion, we next assessed the effect of ICV leptin on SOCS3 mRNA
in MBH (Figure 1D). Leptin rapidly increased MBH levels of
SOCS3 mRNA by more than 3-fold, and this effect was abol-
ished by the central administration of the STAT3 PI (Figure 1D).
Collectively, these observations indicate that this experimental
approach generates a rapid and selective loss of function in
the signaling of leptin through the STAT3 pathway.
Leptin’s anorectic action requires central signaling
through STAT3
Leptin potently regulates feeding behavior. Hyperphagia is
a prominent feature of mice lacking STAT3 in neurons as well
as of mice lacking leptin signaling through STAT3 (Gao et al.,
2004; Bates et al., 2003). The anorectic action of leptin can be
demonstrated after a single bolus injection of the hormone (Pel-
leymounter et al., 1995; Halaas et al., 1995). Here, we tested
whether the acute effects of leptin on food intake are dependent
on the central activation of STAT3. Two hours before the onset
of the dark cycle, a single bolus injection of 1.5 mg of recombi-
nant leptin was administered ICV to conscious rats (experimen-
tal protocol: Figure 2A). Leptin decreased food consumption
over the following 3 hr by 63% compared with ICV injections
of either the STAT3 PI alone or vehicle (Figure 2B). Leptin also
decreased food consumption over the following 24 hr by 30%
compared with ICV injections of either the STAT3 PI alone or ve-
hicle (Figures 2B and 2C). The decrease in food intake was also
reflected in parallel leptin-induced changes in body weight
(Figure 2D). The coinfusion of the STAT3 PI with leptin negated
the effects of leptin on food intake and body weight (Figures
2B–2D). Thus, the acute anorectic action of leptin requires the
central activation of the STAT3 pathway.
Leptin’s effect on luteinizing hormone secretion
in starved female rats requires central signaling
through STAT3
A well-characterized acute effect of leptin on the reproductive
axis is the restoration of the LH surge in food-deprived female
rats (Watanobe et al., 1999; Kalra et al., 1998; Nagatani et al.,
1998; Watanobe and Schioth, 2001). To test whether this acuteprevented by coadministration of the STAT3 PI. Notably, the pre- and coadministration of the STAT3 PI does not suppress leptin-induced activation of Erk1/2. Adminis-
tration of the STAT3 PI was able to inhibit STAT3 activation up to 180 min (C) after leptin administration.
D) mRNA levels of SOCS3 in the MBH 90min after ICV injection of vehicle, leptin, or leptin plus the STAT3 PI. Leptin induces a >3-fold increase in SOCS3mRNA levels that
is prevented once the STAT3 pathway of LRb signaling is inhibited. p = 0.11 for the vehicle-treated group compared to leptin plus STAT3PI. *p < 0.05 versus the ICV vehicle-
treated group.51
A R T I C L EFigure 2. Activation of STAT3 is required for leptin’s anorectic effect
A) Experimental protocol. On day 0, rats received a single ICV injection of vehicle, 1.5 mg of leptin, 75 pmol of the STAT3 PI, or 1.5 mg of leptin plus 75 pmol of the STAT3 PI.
Daily food intake and body weight were measured for 3 days.
B) Food intake at 3 hr and 1–3 days after ICV administration of the indicated substances.
C) Changes in food intake from baseline.
D) Daily body weight during the indicated treatments. *p < 0.05 versus the ICV vehicle-treated group.effect of leptin on the reproductive axis is STAT3 dependent,
ovariectomized female rats were food deprived for 72 hr and
primed with estradiol and progesterone as described (experi-
mental protocol: Figure 3A) (Watanobe and Schioth, 2001; Wa-
tanobe et al., 1999). Baseline LH levels were comparable in the
three treatment groups (vehicle, 4.9 ng/ml; leptin, 4.5 ng/ml; lep-
tin plus STAT3 PI, 5.1 ng/ml; p > 0.05). Serial measurements of
LH from animals treated with ICV vehicle, leptin (2.5 mg/5 ml), and
leptin plus the STAT3 PI (75 pmol) are depicted in Figure 3C. In
total, only one out of the seven vehicle-injected rats exhibited
a detectable LH surge, whereas six animals had no detectable
LH surge. A single bolus of leptin administered ICV at approxi-
mately 10:00 a.m. was able to restore the LH surge in seven
out of seven rats, consistent with previous reports (Watanobe
and Schioth, 2001; Watanobe et al., 1999). This action of leptin
was obliterated by the pre- and coadministration of the STAT3
PI in that six out of seven animals that received leptin plus the
STAT3 PI had no surge. Peak LH levels were also significantly
higher in the leptin-infused animals (28.6 6 3.4 ng/ml) than in
rats treated with vehicle alone (11.2 6 3.2 ng/ml) or leptin plus
STAT3 PI (12.56 5.5 ng/ml) (Figure 3B). Thus, the effect of leptin
on the secretion of LH is dependent on the central activation of
the STAT3 pathway.52Leptin’s regulation of liver glucose fluxes requires
central signaling through STAT3
Leptin has long been recognized to have potent effects on insu-
lin action and on glucose metabolism that are independent of its
actions on energy balance (Rossetti et al., 1997; Gutierrez-
Juarez et al., 2004). Short-term overfeeding rapidly induces he-
patic insulin resistance (Wang et al., 2001), and this defect is
completely reversed by the acute administration of leptin into
the third cerebral ventricle (Pocai et al., 2005b). Here, we ask
whether this effect of central leptin on liver glucose fluxes re-
quires intact STAT3 signaling (Figure 4A). Toward this end we
used two complementary approaches designed to negate leptin
activation of STAT3 in the hypothalamus: the central administra-
tion of the STAT3 PI discussed above and the adenovirus-medi-
ated expression of a dominant-negative mutant of STAT3
(STAT3 DN) in the MBH (Figure 4A). Because leptin can acutely
modulate insulin secretion (Cases et al., 2001), we tested the
central STAT3-dependent effects of leptin on hepatic glucose
fluxes in the presence of fixed and basal plasma insulin concen-
trations. Accordingly, we combined the ICV infusion of vehicle,
leptin (1.5 mg/6 hr), or leptin plus the STAT3 PI (7.5 pmol) with
pancreatic basal insulin (w20 mU ml21) clamps (Figure 4B). The
plasma glucose, insulin, and free fatty acid (FFA) concentrationsCELL METABOLISM : JULY 2006
Leptin regulation of liver glucose metabolismFigure 3. Activation of STAT3 is required for leptin-dependent restoration of LH surges in starved female rats
A) Experimental protocol. Rats underwent ovariectomy and placement of the ICV cannula on day 1. After 7 days of recovery, vascular catheters were implanted and food
was removed to begin a 3 day fast. On day 8 and 9 rats were primed with estradiol, and on day 10 they were injected with progesterone to trigger a LH surge.
B) Peak LH value after progesterone injection.
C) Serial measurements of LH levels from individual animals treated with ICV vehicle (upper panel), 2.5 mg of leptin (middle panel), and leptin (2.5 mg) plus the STAT3 PI
(75 pmol) (lower panel).were similar in the three groups prior to and during the clamp
procedure (Table S1 in the Supplemental Data available with
this article online). In the presence of basal insulin levels, negli-
gible amounts of glucose had to be infused in rats receiving ICV
vehicle. However, when leptin was given centrally a glucose in-
fusion ofw6mg/kg perminute was required to prevent hypogly-
cemia (Figure 4C). The ICV coadministration of the STAT3 PI
with leptin abolished this effect of central leptin on glucose me-
tabolism (Figure 4C). Next, we determined glucose kinetics by
tracer dilution methodology in order to examine whether the
STAT3-dependent effect of central leptin on glucose require-
ments was due to the stimulation of glucose utilization or to
the inhibition of glucose production. ICV leptin failed to alter glu-
cose utilization (Figure 4E) but markedly suppressed glucose
production (by 49% 6 4.3%; Figure 4D). This effect entirelyCELL METABOLISM : JULY 2006accounted for the effect of leptin on glucose infusion and was
negated by the central inhibition of STAT3 activation.
GP represents the net contribution of glucosyl units derived
from gluconeogenesis and glycogenolysis. However, a portion
of glucose entering the liver via phosphorylation of glucose is
also a substrate for dephosphorylation via glucose-6-phospha-
tase (G6Pase), creating a futile cycle named glucose cycling. To
further define the mechanism by which central activation of
STAT3 by leptin rapidly modulates liver glucose homeostasis,
we estimated the in vivo flux through G6Pase and the relative
contributions of gluconeogenesis and glycogenolysis to glucose
production (Table S2). ICV leptin decreased the flux through
G6Pase and glucose cycling by w50% (Figures 5A and 5B),
and these effects were negated by the coinfusion of the STAT3
PI. The marked effects of ICV leptin on glucose production53
A R T I C L EFigure 4. Activation of STAT3 is required for leptin regulation of glucose production
A) To acutely inhibit the STAT3 pathway of LRb signaling, we employed two approaches, the STAT3 PI and the adenovirally mediated expression of a dominant-negative
mutant of STAT3 (STAT3DN).
B) Experimental protocol for the pancreatic basal insulin clamp studies in combination with ICV leptin or vehicle infusions. This protocol is common to experiments reported
here with the ICV infusion of STAT3 PI and to those in rats with MBH administration of STAT3DN adenovirus (Figure S1).
C) Central administration of leptin markedly increases the rate of glucose infusion that is required to prevent hypoglycemia. This effect is negated by the central coadmin-
istration of the STAT3 PI.
D) Rate of glucose production during the clamp studies.
E) Glucose uptake. *p < 0.05 versus the ICV vehicle-treated group.and G6Pase flux were accounted for by a 48% decrease in gly-
cogenolysis (Figure 5C; 4.2 6 0.3 versus 8.1 6 1.0 mg/kg$min;
p < 0.01) and by a 63% decrease in the rate of gluconeogenesis
(Figure 5D; 1.5 6 0.1 versus 4.1 6 0.6 mg/kg$min; p < 0.01)
when compared with the vehicle-infused group. The suppres-
sive effects of ICV leptin on gluconeogenesis and glycogenoly-
sis were prevented by the ICV coinfusion of the STAT3 PI. Thus,
central leptin restrains hepatic glucose fluxes through its central
activation of the STAT3 pathway. Leptin also markedly inhibited
the hepatic expression of G6Pase and phosphoenolpyruvate
carboxykinase (PEPCK) (Figures 5E and 5F). These changes in
liver mRNA expression were also negated by the central coad-
ministration of the STAT3 PI (Figures 5E and 5F).
An alternative experimental approach to induce a selective in-
hibition of leptin signaling through STAT3 is to infect the MBH
with an adenovirus expressing STAT3 DN (Figure S1A) (Inoue
et al., 2004). Oneweek after theMBH infusion of this adenovirus,
STAT3 overexpression was demonstrated in MBH extracts
(Figure S1B). The expression of the STAT3 DN led to marked in-
hibition of leptin-induced STAT3 Y705 phosphorylation in the
MBH compared to LacZ control-infected rats (Figure S1B),
whereas the basal level of Stat3 Y705 phosphorylation in the
MBH was not altered by Stat3 DN expression (data not shown).
To verify the critical role of central STAT3 in mediating the action
of leptin on glucose production, we assessed the acute effects54of leptin on glucose metabolism in overfed rats 1 week after the
MBH infusion of adenovirus expressing either STAT3 DN or
LacZ (experimental protocol: Figure S1A). Toward this end, we
combined the MBH infusion of leptin with pancreatic basal insu-
lin (w20 mU ml21) clamps in rats. The plasma glucose, insulin,
and FFA concentrations were similar in the two groups prior to
and during the clamp procedure. In the presence of basal insulin
levels, central leptin markedly stimulated glucose metabolism
so that exogenous glucose was required to prevent hypoglyce-
mia in rats treated with the LacZ adenovirus (Figure S1C). This
effect was entirely accounted for by a marked decrease in glu-
cose production (Figure S1D). The expression of the STAT3
DN in the MBH abolished the effect of central leptin on glucose
metabolism and on glucose production (Figure S1D). Taken to-
gether, the results obtained with STAT3 PI and STAT3 DN ade-
novirus demonstrate that MBH STAT3 signaling is required for
leptin’s ability to suppress hepatic glucose fluxes in rats with
diet-induced insulin resistance.
Severe hepatic insulin resistance is a common feature
of db/db and s/s mice
Mice carrying a leptin receptor gene mutant for Tyr1138 (s/s
mice) fail to mediate the activation of STAT3 by leptin (Bates
et al., 2003). These s/smice lack leptin’s ability to signal through
STAT3. s/s mice pair-fed to the level of control mice sinceCELL METABOLISM : JULY 2006
Leptin regulation of liver glucose metabolismFigure 5. Activation of STAT3 is required for leptin
regulation of liver glucose fluxes
A) Flux through G6Pase.
B) Glucose cycling.
C) Rate of glycogenolysis.
D) Rate of gluconeogenesis.
E) G6Pase mRNA.
F)PEPCKmRNA expression in livers at the end of the
clamp procedure. *p < 0.05 versus the ICV vehicle-
treated group.weaning do not develop hyperglycemia or glucose intolerance
at least up to 8 weeks of age (Bates et al., 2005). However, the
same degree of caloric restriction mitigates, but fails to normal-
ize, glucose intolerance in 8-week-old db/db mice. These find-
ings suggest that leptin partly controls glucose tolerance
throughSTAT3-independent pathway(s). Here,weused a similar
experimental approach in order to examine whether differences
in hepatic insulin action are responsible for the improved glu-
cose tolerance in s/s compared with db/db mice. We studied
11-week-old control, s/s, and db/db mice fed 3.8 g/day since
weaning (w4-week-old) (experimental protocol: Figure 6A).
Consistent with previous findings in younger mice, the average
glycemia of db/db mice was significantly higher than that of s/s
mice (Table S3). During the insulin clamp studies, the plasma
glucagon levels as well as the increment in circulating insulin
levels above basal were similar in all groups. However, despite
improved glycemia, insulin clamp studies revealed severe he-
patic insulin resistance in s/s mice (Figure 6B). Indeed, the de-
gree of hepatic insulin resistance was similar in s/s and db/db
mice, suggesting that the difference in glucose tolerance is
due to alternative mechanisms such as subtle differences in
endocrine parameters and/or in extrahepatic insulin sensitivity.
In this regard, the rates of glucose infusion and glucose uptake
tended to be higher in s/s compared with db/db mice (FiguresCELL METABOLISM : JULY 20066C and 6E). Thus physiological increases in plasma insulin levels
elicit similar effects in s/s mice (with intact STAT3-independent
effects) and in db/db mice (with lack of both STAT3-dependent
and -independent effects). This suggests that acute and chronic
effects of leptin on hepatic glucose fluxes are mediated via a
STAT3-dependent pathway.
Discussion
Rapid loss of function in central STAT3 signaling
Leptin exerts pleiotropic actions on energy balance, glucose ho-
meostasis, and reproduction (Ahima and Flier, 2000). Although
the hypothalamic STAT3 pathway is regarded as a central medi-
ator of leptin action, its role in the acute effects of leptin has not
been addressed. Current information on the role of STAT3 in lep-
tin action is exclusively derived from the phenotype of genetic
models designed to harbor a loss of functionwithin this signaling
pathway. Because even modest changes in body composition
and nutritional status can alter critical endocrine and metabolic
parameters, a rapid induction of STAT3 loss of function is re-
quired in order to define the role of STAT3 in mediating these
effects of leptin (Barzilai et al., 1999). Unfortunately, the lack
of a specific inhibitor has so far hampered our ability to map55
A R T I C L EFigure 6. Glucose homeostasis in s/s and db/db
mice
A) Experimental design for the clamp studies in wild-
type (WT), db/db, and s/s mice. All mice received
w3.8 grams of chow from day 28 until clamp study.
B) Glucose infusion rate during the clamp studies in
WT, s/s, and db/db mice.
C) Glucose production.
D) Glucose uptake during the clamp in WT, s/s, and
db/db mice.downstream actions of leptin that are dependent on or indepen-
dent of STAT3.
At the single-cell level, the functional anatomy of signal trans-
duction has greatly benefited by the use of phosphopeptides
designed to specifically and selectively inhibit a stepwithin a sig-
naling pathway in order to unveil its physiological role (Dunican
and Doherty, 2001). Here, we validate the use of a cell-perme-
able phosphopeptide to block LRb-induced STAT3 activation
in vivo. The combination of this approach with stereotaxic surgi-
cal techniques allowed us to pinpoint the role of hypothalamic
STAT3 in several biological actions of leptin. Perhaps more
importantly, the use of this and other cell-permeable inhibitor
peptides should provide a formidable tool for the functional
mapping of central signaling and metabolic events, and for the
assessment of their impact on key behavioral and metabolic
end points.
The focus of the present study is the role of STAT3 in mediat-
ing the acute effects of central leptin on feeding behavior, liver
glucose metabolism, and gonadotropin secretion. To this end
we selectively blocked leptin’s ability to activate STAT3 in con-
scious rats and then assessed the effects of central leptin on
physiological end points.
Leptin and feeding behavior
Genetic evidence firmly implicates the neuronal STAT3 pathway
in the regulation of food intake (Gao et al., 2004; Bates et al.,
2003). In the present study, we postulated that the central acti-
vation of STAT3 by leptin would be required for its rapid action
on food intake. A rapid loss of function in central STAT3 activa-
tion negated the anorectic action of leptin. Thus, the marked hy-
perphagia induced by lifelong obliteration of either neuronal or
LRb specific STAT3 signaling is largely due to a lack of STAT3
function in the adult brain rather than to STAT3-dependent
changes in the development of hypothalamic neuronal circuit-
ries (Bates et al., 2003; Gao et al., 2004; Cui et al., 2004; Goro-
gawa et al., 2004).56Notably, the central inhibition of PI3K, AMP-activated protein
kinase (AMPK), or melanocortin receptors also abolished the
acute effects of leptin on feeding behavior. Is STAT3 upstream
of these other downstream effector pathways? There is strong
evidence in support of STAT3-dependent regulation of pro-
opiomelanocortin (POMC) neurons and therefore of the central
melanocortin pathway (Bates et al., 2003). Conversely, the role
of STAT3 in mediating the effects of leptin on PI3K and AMPK
has not been defined. Our finding suggests either that the lep-
tin-induced activation of STAT3 is required for the activation of
PI3K and for the inhibition of AMPK in the hypothalamus or
that parallel signaling events play a critical permissive role in
mediating the anorectic effects of leptin (Kitamura et al., 2006).
Leptin and reproductive function
Leptin is one critical indicator of nutrient/energy sufficiency that
is a prerequisite for successful reproduction. In anorectic fe-
males and in some elite female athletes with extreme decreases
in body adiposity, the near disappearance of leptin from the
circulation is the main cause for the cessation of the menstrual
cycle. This is largely due to the inadequate secretion of gonad-
otropins (LH and follicle stimulating hormone) by the pituitary
gland (hypogonadotropic hypogonadism). Importantly, the ad-
ministration of very low doses of recombinant leptin can restore
themenstrualcyclewithoutaffecting food intake (Welt etal., 2004).
Neuronal deletion of STAT3 in mice leads to infertility (Gao
et al., 2004). On the other hand, s/s mice display relatively nor-
mal fertility. One possible interpretation of these findings could
be that hypothalamic STAT3 signalingmediated by factors other
than leptin is permissive for leptin’s effects on reproductive
function in normally fed animals. Our findings, however, strongly
suggest that in starved females, STAT3-dependent effects in the
hypothalamus are required for leptin to promote spontaneous
LH surges. In s/s mice, it is possible that leptin signaling by
STAT3-independent mechanisms partially restores reproductive
function by permitting pulsatile gonadotropin release, resultingCELL METABOLISM : JULY 2006
Leptin regulation of liver glucose metabolismin low levels of estradiol that are not sufficient to support spon-
taneous preovulatory LH surges. These low levels of estradiol
might be sufficient to permit mating to occur on occasion, and
the resulting somatosensory stimulation could provoke a normal
LH surge (Gibson et al., 1988). This situation might explain why
s/s breeding pairs have normal litter sizes when they do repro-
duce but produce only half as many litters as wild-type mice.
Leptin regulation of liver glucose homeostasis
Rodents with leptin deficiency are severely resistant to the ac-
tion of insulin on glucose metabolism and often present with
frank diabetes. Leptin regulates glucose metabolism and insulin
secretion at multiple levels through its central as well as periph-
eral actions. Some of the effects of leptin on glucose homeosta-
sis are independent of its anorectic action. Among the mecha-
nisms by which leptin improves glucose tolerance are its
effects on the accumulation of triglycerides in various tissues,
such as pancreas, liver, and muscle, and its regulatory control
of hepatic glucose homeostasis. In this regard, leptin modulates
hepatic insulin action via central melanocortin-dependent ef-
fects, leading to increases in the liver expression of G6Pase
and PEPCK, in the rate of gluconeogenesis, and, via melanocor-
tin-independent effects leading to inhibition of the liver expres-
sion of these two enzymes and of the rate of glycogenolysis (Gu-
tierrez-Juarez et al., 2004). Importantly, leptin normalizes insulin
action in a rat model in which severe hepatic insulin resistance is
rapidly induced by voluntary overfeeding (Pocai et al., 2005b).
Here, we used two distinct biochemical and molecular ap-
proaches to acutely and selectively blunt the action of leptin
on hypothalamic STAT3 signaling in rats with hepatic insulin re-
sistance. These experiments indicate that the ability of central
leptin to restrain hepatic glucose fluxes andG6Pase and PEPCK
gene expression requires the activation of the STAT3 pathway,
within the MBH. These findings are consistent with emerging
evidence regarding the critical role of the arcuate nucleus of
the hypothalamus in the control of glucose homeostasis by insu-
lin (Obici et al., 2002a; Pocai et al., 2005a), nutrients (Lam et al.,
2005; Obici et al., 2002b), and leptin (Morton et al., 2005; Cop-
pari et al., 2005). As previously reported for the regulation of
feeding behavior, the effects of insulin and leptin on glucose ho-
meostasis have been shown to be dependent on the activation
of the PI3K pathway within the MBH (Niswender et al., 2001). To
reconcile the present findings with these previous reports, one
has to postulate that either the activation of STAT3 is required
for the activation of PI3K and/or that STAT3 exerts a permissive
effect that is necessary for leptin modulation of glucose metab-
olism (Kitamura et al., 2006).
Mice with a selective deficiency in leptin signaling through
STAT3 (s/s) display improved glucose tolerance compared
with mice lacking LRb (db/db) (Bates et al., 2005). Here, we con-
firm that early caloric restriction prevents the onset of hypergly-
cemia in s/smice up to 11 weeks of age, while the same degree
of food restriction only ameliorates but does not normalize gly-
cemia in db/db mice. To directly assess insulin action in these
two models, we performed insulin clamp studies in conscious
s/s and db/db mice. We show that db/db and s/s mice share
a severe defect in insulin action on hepatic glucose fluxes that
is not improved by the presence of STAT3-independent signal-
ing in the s/s mice. These findings in mice provide further sup-
port for the notion that leptin controls hepatic glucose homeo-
stasis through the central activation of STAT3 signaling.CELL METABOLISM : JULY 2006We demonstrate here that a rapid loss of function in STAT3
signaling can be induced in vivo using a cell-permeable inhibi-
tory peptide. The targeting of this peptide to discrete brain
regions should provide a formidable tool for dissecting the con-
tribution of this pathway to signal transduction and to physiolog-
ical processes. Using this experimental tool, we unveil the criti-
cal role of leptin-induced activation of STAT3 in the regulation of
food intake, gonadotropin secretion, and liver glucose fluxes.
Since leptin deficiency or resistance leads to obesity, diabetes,
and reproductive dysfunction, our findings suggest that restora-
tion of STAT3 signaling should be a central objective of the ther-
apy for these conditions.
Experimental procedures
Animals
Rats
Adult male (for feeding, signaling, and clamp studies) and adult female (for
the LH surge experiments) Sprague-Dawley rats (Charles River Laboratories,
Wilmington, Massachusetts) were studied. Rats were housed in individual
cages and subjected to a standard light-dark cycle (lights on at 6 a.m.). Four-
teen days before the in vivo study, indwelling catheters were placed either in
the third cerebral ventricle or in the MBH by stereotaxic surgery as described
(Obici et al., 2002a). The anatomical placement of the bilateral cannulae was
validated via infusion of radio-labeled molecules as described (Pocai et al.,
2005a), followed by anatomical sampling by micro punches. Radioactivity
was recovered only in arcuate, but not in other hypothalamic areas. Following
full recovery (w7 days), catheters were placed in the right internal jugular and
left carotid artery. As indicated, rats were fed either a standard chow or a
highly palatable high-fat diet for 3 days as described (Pocai et al., 2005b).
The standard chow diet (catalog no. 5001; Purina Mills) contained 59% cal-
ories provided by carbohydrates, 20% provided by protein, and 21% by fat.
The high-fat diet (catalog no. 9398; Purina Mills Ltd.) contained 45% of cal-
ories provided by carbohydrates, 22% provided by protein, and 33% pro-
vided by fat. Starch was themain carbohydrate source in both diets, whereas
sucrose accounted forw3.5%.
Mice
Mice with the Leprs1138 mutation on C57BL/6 background have been de-
scribed (Bates et al., 2003). C57BL/6 db/db animals were obtained from
the Jackson Laboratory (Bar Harbor, Maine). Db/db and s/s mice were
pair-fed to the daily food intake of wild-type mice starting at 4 weeks of
age (average of 3.8 g/day).
STAT3 PI
The sequence of the STAT3 PI was PYLKTKAAVLLPVLLAAP (where the
membrane translocating sequence is underlined) as described (Turkson
et al., 2001). The control peptide sequence was PLKTYKAAVLLPVLLAAP
and was derived by scrambling the sequence of the STAT3 PI and fusion
of this sequence to the intact membrane translocating sequence. Both pep-
tides were synthesized by the protein facility of AECOM and HPLC purified.
Feeding studies
Rats had ICV cannulae implanted, and after complete recovery they were
randomized in three groups. Two hours before onset of the dark cycle,
they received a single ICV infusion of vehicle (artificial cerebrospinal fluid
[aCSF]), 1.5 mg of recombinant mouse leptin, or 1.5 mg of leptin plus 75
pmol of the STAT3 PI in a total volume of 5 ml over 5 min. Food intake and
body weight were monitored at the indicated time points (Figure 2A).
LH surge studies
Female Sprague-Dawley rats (220–240 g) were ovariectomized and had their
third ventricle chronically cannulated under general anesthesia 7 days before
the study. Indwelling jugular vein cannulae were placed 3 days before blood
collection. Animals were then fasted for 3 days prior to collection of blood
samples to measure LH release (Nagatani et al., 1998; Watanobe and
Schioth, 2001). On the second day of fasting, all animals received estradiol
benzoate (2 mg) subcutaneously daily for 2 days (Figure 3A). At about 9:00
a.m. on the day of the experiment (2 days after the first estradiol injection),57
A R T I C L E500 mg of progesterone was injected subcutaneously. Blood samples (200 ml)
were collected every 60 min over a total period of 480 min (10:00 a.m.–6:00
p.m.). At 10:00 a.m. the rats received ICV either vehicle (5 ml over 5 min) or
STAT3 PI (75 pmol/5 ml) followed 30 min later by an ICV injection of 2.5 mg
of leptin or vehicle in a total volume of 5 ml over 5 min (Watanobe et al.,
1999; Watanobe and Schioth, 2001). Hourly plasma samples were obtained
and stored at 280 until further assay for LH via ELISA (Amersham, NJ).
Euglycemic/hyperinsulinemic clamp studies
Pancreatic insulin clamp studies in mice were performed as previously
described to obtain physiological hyperinsulinemia (Buettner et al., 2005).
Pancreatic basal insulin clamp studies in rats were performed as described
(Pocai et al., 2005a).
Injection of STAT3 DN and control LacZ adenovirus
STAT3 DN adenovirus was a generous gift of Dr. Masato Kasuga andwas de-
rived as described (Inoue et al., 2004; Minami et al., 1996). LacZ and STAT3
DN adenovirus were purified by CsCl gradient centrifugation and concen-
trated to 1.3 3 1010 plaque-forming units per ml, corresponding to 2.5 3
1012 viral particles per ml. Rats were injected stereotaxically via the im-
planted cannulae into the MBH with either STAT3 DN or LacZ (1 ml = 2.5 3
103 9 particles). Rats were analyzed by clamp studies 7 days after injection.
Real-time PCR
Real-time PCR was performed as described (Gutierrez-Juarez et al., 2004;
Pocai et al., 2005c).
Signaling studies and Western blot analysis
For signaling studies, rats were injected ICV with either 5 ml of vehicle (aCSF),
75 pmol of STAT3 PI, or 75 pmol of control PI (dissolved in aCSF) over 5 min,
followed 30 min later by the injection of either 2.5 mg of leptin (5 ml of 0.5 mg/ml
over 5 min) or vehicle (aCSF) or 2.5 mg of leptin plus 75 pmol of STAT3 PI
or control PI as indicated and sacrificed 30 min later. The arcuate nucleus
was dissected by punch biopsy using a needle with 0.5 mm diameter as de-
scribed (Obici et al., 2003) and homogenized in 20 mM MOPS, 2 mM EGTA,
5 mM EDTA, 30 mM sodium fluoride, 40 mM b-glycerophosphate, 10 mM
sodium pyrophosphate, 2 mM orthovanadate, 0.5% NP-40, and complete
protease inhibitors cocktail (Roche, Indianapolis, IN). To confirm overexpres-
sion of the adenovirally mediated expression of STAT3 DN, 7 days after infec-
tion the MBH was isolated as described (Pocai et al., 2005b). Samples were
run at least twice on two separate gels for quantification purposes. Primary
antibodies against phospho-Akt473, phospho-Akt308, Akt p42/44, phos-
pho-p42/44, and STAT3 Y705 were from Cell Signaling Technology, Inc.,
Beverly, MA, and primary antibody against Stat 3 and goat anti-rabbit and
anti-mouse HRP-conjugated secondary antibodies (Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA) were used with ECL reagents (Perkin Elmer, Bos-
ton, MA). Membranes were stripped with the stripping agent Restore (Pierce,
Rockford, IL) according to the protocol of the manufacturer and reprobed
with the housekeeping genes actin (Abcam, Cambridge, MA) and GAPDH
(RDI, Flanders, NJ) to ensure equal loading. Band intensity on autoradio-
graphic Kodak MS films was quantified by application of ImageQuant soft-
ware (Amersham, NJ).
Analytical procedures
The levels of glucose and FFAs, the [3H]glucose radioactivity, the rate of glu-
cose uptake, and endogenous glucose production were calculated as previ-
ously described (Rossetti et al., 1993).
Measurement of hormones
Plasma levels of insulin, glucagons, and leptin were measured as described
(Neal-Perry et al., 2005; Buettner et al., 2005).
Hepatic glucose fluxes
Hepatic glucose fluxes were measured as described (Barzilai et al., 1997).
Statistics
All values are presented as mean 6 SEM. Differences were considered sta-
tistically significant at p < 0.05. Comparisons among groups were made us-
ing ANOVA followed by an unpaired Student’s t test. The study protocol was
reviewed and approved by the Institutional Animal Care and Use Committee
of the Albert Einstein College of Medicine.58Supplemental data
The Supplemental Data include three supplemental tables and one supple-
mental figure and can be found with this article online at http://www.
cellmetabolism.org/cgi/content/full/4/1/49/DC1/.
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